Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Equity Average (2021 - 2025)

Historic Equity Average for Rapid Micro Biosystems (RPID) over the last 5 years, with Q3 2025 value amounting to $49.4 million.

  • Rapid Micro Biosystems' Equity Average fell 4474.97% to $49.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.4 million, marking a year-over-year decrease of 4474.97%. This contributed to the annual value of $96.7 million for FY2024, which is 3147.78% down from last year.
  • Per Rapid Micro Biosystems' latest filing, its Equity Average stood at $49.4 million for Q3 2025, which was down 4474.97% from $60.0 million recorded in Q2 2025.
  • Rapid Micro Biosystems' Equity Average's 5-year high stood at $227.9 million during Q4 2021, with a 5-year trough of $35.1 million in Q3 2021.
  • For the 5-year period, Rapid Micro Biosystems' Equity Average averaged around $127.0 million, with its median value being $122.9 million (2023).
  • Its Equity Average has fluctuated over the past 5 years, first surged by 43259.52% in 2022, then plummeted by 4474.97% in 2025.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' Equity Average stood at $227.9 million in 2021, then decreased by 24.69% to $171.6 million in 2022, then dropped by 28.38% to $122.9 million in 2023, then plummeted by 35.01% to $79.9 million in 2024, then crashed by 38.1% to $49.4 million in 2025.
  • Its last three reported values are $49.4 million in Q3 2025, $60.0 million for Q2 2025, and $70.4 million during Q1 2025.